Exercise-induced asthma: Is it the right diagnosis in elite athletes?

Slides:



Advertisements
Similar presentations
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Advertisements

Bronchial Hyperresponsiveness in the Assessment of Asthma Control
Bronchial Hyperresponsiveness in the Assessment of Asthma Control
Recognition and First-Line Treatment of Anaphylaxis
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Diagnostic Accuracy of Inflammatory Markers for Diagnosing Occupational Asthma  Geneviève Racine, Roberto Castano, MD, PhD, André Cartier, MD, Catherine.
Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M
The effects of upper respiratory infection on T-cell proliferation and steroid sensitivity of asthmatics  Elcio O. Vianna, MD, PhD, Jay Westcott, PhD,
Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.
Asthma diagnosis and treatment: Filling in the information gaps
Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma  Patrick Booms, MSca, David.
Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin a- induced bronchoconstriction  Nunzio Crimi, MD, Corrado Pagano, MD,
Overcoming barriers to nonadherence in asthma treatment
Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,
Rosa Codina, PhD, Richard F. Lockey, MD 
Aspirin-induced urticaria and angioedema, but not bronchoconstriction, associated with cysteinyl leukotriene overproduction in 2 patients with asthma 
Is 9 more than 2 also in allergic airway inflammation?
T lymphocytes in asthma: Bronchial versus peripheral responses
Badrul A. Chowdhury, MD, PhD 
Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,
A history of pollen mapping and surveillance: The relations between natural history and clinical allergy  Gregg Mitman, PhD  Journal of Allergy and Clinical.
Xaver Baur  Journal of Allergy and Clinical Immunology 
Adverse effects of β-agonists
The impact of allergic rhinitis on bronchial asthma
Nonadherence to Asthma Treatment: Getting Unstuck
Inhaled corticosteroids: Impact on asthma morbidity and mortality
Peter König, MD, PhD  Journal of Allergy and Clinical Immunology 
H.William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Paul M. O’Byrne, MB, FRCPI, FRCP(C)a, Soren Pedersen, MD, PhDb 
A methodological assessment of diurnal variability of peak flow as a basis for comparing different inhaled steroid formulations  John H. Toogood, MD,
Robert A. Wood, MD, Wanda Phipatanakul, MD, Robert G
A review of the current guidelines for allergic rhinitis and asthma
News & Notes Journal of Allergy and Clinical Immunology
Correlation between alcohol-induced asthma and acetaldehyde dehydrogenase-2 genotype  Atsuko Takao, MDa, Terufumi Shimoda, MDa, Shigeru Kohno, MDa, Sadahiro.
Circadian variation of sputum inflammatory cells in mild asthma
Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization  Qutayba Hamid, MD, PhD, Editor  Journal.
Effect of β-adrenergic agonists on mucociliary clearance
Wine-induced asthma: A placebo-controlled assessment of its pathogenesis  Hassan Vally, BSc (Hons), Amanda Carr, BAppSc, Jacque El-Saleh, RN, Philip Thompson,
The editors' choice Journal of Allergy and Clinical Immunology
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study  Jacques de Blic, MDa, Christophe Delacourt, MDa, Muriel.
Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma  William.
Effects of β2-agonists on airway tone and bronchial responsiveness
Exercise-induced bronchoconstriction in children: Montelukast attenuates the immediate-phase and late-phase responses  Raul E. Melo, MD, Dirceu Solé,
Peter S. Creticos, MD  Journal of Allergy and Clinical Immunology 
Clinical need for a nebulized corticosteroid
Gross pathology and histopathology of asthma
News & Notes Journal of Allergy and Clinical Immunology
Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma  Eugene R. Bleecker, MDa, Michael J. Welch, MDb,
Clinical effects of nedocromil sodium on challenges invoking neuronal mechanisms and on virally induced symptoms  Peter König, MD, PhD  Journal of Allergy.
Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation  Anthony P. Sampson, PhDa, Emilio Pizzichini, MD, PhDb,
Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy  Padmaja Subbarao, MD, MSc, Sandra C. Dorman,
Plasma adenosine concentration increases during exercise: A possible contributing factor in exercise-induced bronchoconstriction in asthma  Éva Vizi,
Leukotriene receptor antagonists in asthma therapy
Allergy and asthma in elite summer sport athletes
The mechanism of exercise-induced asthma is …
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma  Jennifer.
Changes in sputum counts and airway hyperresponsiveness after budesonide: Monitoring anti-inflammatory response on the basis of surrogate markers of airway.
Robert P. Schleimer, PhD  Journal of Allergy and Clinical Immunology 
Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy  Diane J. Pincus, MD, Teresa R. Humeston,
Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M
Footnotes1 Journal of Allergy and Clinical Immunology
10. Drug allergy Journal of Allergy and Clinical Immunology
National trends in asthma visits and asthma pharmacotherapy,
Prescott G. Woodruff, MD, MPH, Ramin Khashayar, MD, Stephen C
Larry C. Borish, MDa, Harold S
Daniel Menzies, MBChB, Arun Nair, MBBS, Karen T
The preventive effect and duration of action of two doses of inhaled furosemide on exercise-induced asthma in children  Elio Novembre, MD, Gianfranco.
Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol 
News & Notes Journal of Allergy and Clinical Immunology
Presentation transcript:

Exercise-induced asthma: Is it the right diagnosis in elite athletes? Sandra D. Anderson, PhD, DSca, Karen Holzer, MB, BSb  Journal of Allergy and Clinical Immunology  Volume 106, Issue 3, Pages 419-428 (September 2000) DOI: 10.1067/mai.2000.108914 Copyright © 2000 Mosby, Inc. Terms and Conditions

Fig. 1 Flow chart describing the events leading to cough, mucus production, and EIA. Journal of Allergy and Clinical Immunology 2000 106, 419-428DOI: (10.1067/mai.2000.108914) Copyright © 2000 Mosby, Inc. Terms and Conditions

Fig. 2 The change in FEV1 in relation to the concentration of agonist required to induce this change. Note that the airways are more sensitive to inhalation of leukotriene compared with methacholine or histamine. (Reprinted with permission from Chest. 1997;111[Suppl 2]:27S-34S.) Journal of Allergy and Clinical Immunology 2000 106, 419-428DOI: (10.1067/mai.2000.108914) Copyright © 2000 Mosby, Inc. Terms and Conditions

Fig. 3 The percentage fall in FEV1 before and during treatment with different doses of budesonide administered by means of inhalation. Asterisks denote a significant difference between the percentage fall compared with the control exercise test. Adapted from J Allergy Clin Immunol. 1995;95:29-33. Journal of Allergy and Clinical Immunology 2000 106, 419-428DOI: (10.1067/mai.2000.108914) Copyright © 2000 Mosby, Inc. Terms and Conditions

Fig. 4 The effects of increasing degree of airway smooth muscle contraction on luminal cross-sectional area are shown schematically, and a plot of airflow resistance as a function of dose of agonist is presented for the case of no airway luminal liquid (a, b, c; solid line) and in the presence of liquid-filled interstices (a’, b’, c’; dashed line) . (Reprinted with permission from Am Rev Respir Dis 1991;143[Suppl]:S52-4.) Journal of Allergy and Clinical Immunology 2000 106, 419-428DOI: (10.1067/mai.2000.108914) Copyright © 2000 Mosby, Inc. Terms and Conditions

Fig. 5 Mean value for the percentage change in lung function usually measured as percentage fall in FEV1 or peak expiratory flow after exercise in the presence of a placebo or the active agent. Journal of Allergy and Clinical Immunology 2000 106, 419-428DOI: (10.1067/mai.2000.108914) Copyright © 2000 Mosby, Inc. Terms and Conditions